August 22, 2017 9:07 AM ET


Company Overview of Genocea Biosciences, Inc.

Key Executives for Genocea Biosciences, Inc.

NameBoard RelationshipsTitleAge
William D. Clark 14 RelationshipsChief Executive Officer, President and Director48
Darren Higgins Ph.D.29 RelationshipsScientific Co-Founder and Member of Scientific Advisory Board--
Jonathan Poole No RelationshipsChief Financial Officer and Secretary42
Seth Hetherington M.D.No RelationshipsChief Medical Officer65
George R. Siber M.D., Ph.D.96 RelationshipsChairman of Scientific Advisory Board and Executive Director72

Genocea Biosciences, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Katrine S. Bosley 36 RelationshipsEditas Medicine, Inc.49
William D. Clark 14 RelationshipsGenocea Biosciences, Inc.48
Darren Higgins Ph.D. 29 RelationshipsGenocea Biosciences, Inc.--
George R. Siber M.D., Ph.D. 96 RelationshipsGenocea Biosciences, Inc.72
Kenneth M. Bate MBA 81 RelationshipsCatabasis Pharmaceuticals, Inc.67
View All Board Members

Genocea Biosciences, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Michael J. Higgins40 Relationships3 Executives
Compensation Committee MBAKenneth M. Bate81 Relationships2 Executives
Nominating Committee Katrine S. Bosley36 Relationships2 Executives
Corporate Governance Committee Katrine S. Bosley36 Relationships2 Executives
Advisory Board M.D., Ph.D.George R. Siber96 Relationships9 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$455.5K
Total Value of Options
Compensation as of Fiscal Year
Genocea Biosciences, Inc. CEO Compensation
Industry Average


Shire plc Announces Executive Changes
August 21, 2017 1:01 PM ET
Ligand Pharmaceuticals Incorporated Appoints Nancy Ryan Gray as Board of Director
August 21, 2017 1:00 PM ET
BIOASIS TECHNOLOGIES INC. Appoints Doug Williams as Executive Vice President, Chief Business Officer
August 21, 2017 12:00 PM ET
Recro Pharma Appoints Jyrki Mattila as Executive Vice President of Business Development
August 21, 2017 11:00 AM ET
Aperiomics of Ashburn Appoints Alvin Chen as Chief Technology Officer
August 21, 2017 6:59 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genocea Biosciences, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at